Table 3.
Adjusted odds of receiving a pneumococcal vaccine among long-term colorectal cancer survivors (Surveillance, Epidemiology, and End Results-Medicare 2000 to 2011; N=32,501).
| Characteristic and category | Receipt of pneumococcal vaccination | |||
|
|
Adjusted odds ratio | 95% CI | P value | |
| Hispanic/Latino (SEERa-North American Association of Cancer Registries Hispanic Identification Algorithm identity) | ||||
|
|
No | Refb | —c | — |
| Yes | 0.888 | 0.798-0.990 | .032 | |
| Age at diagnosis (years) | ||||
| 66-69 | Ref | — | — | |
| 70-74 | 1.14 | 1.063-1.222 | <.001 | |
| 75-79 | 1.055 | 0.984-1.132 | .13 | |
| 80-84 | 0.991 | 0.920-1.068 | .82 | |
| >85 | 0.848 | 0.780-0.923 | <.001 | |
| Charlson Comorbidity Score | ||||
| 0 | Ref | — | — | |
| 1 | 1.344 | 1.274-1.418 | <.001 | |
| 2 | 1.47 | 1.348-1.602 | <.001 | |
| 3 or more | 1.437 | 1.262-1.636 | <.001 | |
| Marital status | ||||
| Single | Ref | — | — | |
| Married | 1.148 | 1.049-1.255 | .003 | |
| Divorced | 0.967 | 0.853-1.096 | .60 | |
| Other | 1.004 | 0.914-1.101 | .94 | |
| Urban status | ||||
| Urban or Metro | 1.298 | 1.206-1.397 | <.001 | |
| Rural | Ref | — | ||
| Census tract federal poverty level (%) | ||||
| 0 to <5 | 1.307 | 1.213-1.408 | <.001 | |
| 5 to <10 | 1.181 | 1.100-1.267 | <.001 | |
| 10 to <20 | 1.108 | 1.033-1.189 | .004 | |
| 20 to 100 | Ref | — | — | |
| Gender | ||||
| Male | Ref | — | — | |
| Female | 1.139 | 1.086-1.194 | <.001 | |
| Tumor stage at diagnosis | ||||
| Local | Ref | — | — | |
| Regional | 0.941 | 0.898-0.985 | .009 | |
| Distant | 0.856 | 0.746-0.982 | .03 | |
| Unstaged | 0.779 | 0.664-0.914 | .002 | |
| SEER registry region | ||||
| San Francisco | 0.964 | 0.851-1.086 | .56 | |
| Connecticut | 1.020 | 0.930-1.120 | .67 | |
| San Jose | 1.220 | 1.046-1.421 | .01 | |
| Los Angeles | 1.036 | 0.943-1.138 | .46 | |
| Greater California | 1.039 | 0.972-1.110 | .26 | |
| New Jersey | 1.000 | 0.936-1.069 | >.99 | |
| New Mexico | 1.312 | 1.127-1.526 | <.001 | |
| All Others | Ref | — | — | |
aSEER: Surveillance, Epidemiology, and End Results.
bServes as reference group, adjusted odds ratio not applicable.
cNot applicable.